A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas

The development of potent and selective therapeutic approaches to glioblastoma (GBM) requires the identification of molecular pathways that critically regulate the survival and proliferation of GBM. Glioblastoma stem-like cells (GSCs) possess stem-cell-like properties, self-renewal, and differentiat...

Full description

Bibliographic Details
Main Authors: Yukiko Nakahara, Hiroshi Ito, Hiroki Namikawa, Takashi Furukawa, Fumitaka Yoshioka, Atsushi Ogata, Jun Masuoka, Tatsuya Abe
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/12/4/473
_version_ 1797436623385788416
author Yukiko Nakahara
Hiroshi Ito
Hiroki Namikawa
Takashi Furukawa
Fumitaka Yoshioka
Atsushi Ogata
Jun Masuoka
Tatsuya Abe
author_facet Yukiko Nakahara
Hiroshi Ito
Hiroki Namikawa
Takashi Furukawa
Fumitaka Yoshioka
Atsushi Ogata
Jun Masuoka
Tatsuya Abe
author_sort Yukiko Nakahara
collection DOAJ
description The development of potent and selective therapeutic approaches to glioblastoma (GBM) requires the identification of molecular pathways that critically regulate the survival and proliferation of GBM. Glioblastoma stem-like cells (GSCs) possess stem-cell-like properties, self-renewal, and differentiation into multiple neural cell lineages. From a clinical point of view, GSCs have been reported to resist radiation and chemotherapy. GSCs are influenced by the microenvironment, especially the hypoxic condition. N-myc downstream-regulated gene 1 (NDRG1) is a tumor suppressor with the potential to suppress the proliferation, invasion, and migration of cancer cells. Previous studies have reported that deregulated expression of NDRG1 affects tumor growth and clinical outcomes of patients with GBM. This literature review aimed to clarify the critical role of NDRG1 in tumorigenesis and acquirement of resistance for anti-GBM therapies, further to discussing the possibility and efficacy of NDRG1 as a novel target of treatment for GBM. The present review was conducted by searching the PubMed and Scopus databases. The search was conducted in February 2022. We review current knowledge on the regulation and signaling of NDRG1 in neuro-oncology. Finally, the role of NDRG1 in GBM and potential clinical applications are discussed.
first_indexed 2024-03-09T11:05:19Z
format Article
id doaj.art-9b44b1d9bcf04a1194990a1412046519
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-09T11:05:19Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-9b44b1d9bcf04a1194990a14120465192023-12-01T00:59:44ZengMDPI AGBrain Sciences2076-34252022-04-0112447310.3390/brainsci12040473A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and GlioblastomasYukiko Nakahara0Hiroshi Ito1Hiroki Namikawa2Takashi Furukawa3Fumitaka Yoshioka4Atsushi Ogata5Jun Masuoka6Tatsuya Abe7Department of Neurosurgery, Saga University, Saga 849-8501, JapanDepartment of Neurosurgery, Saga University, Saga 849-8501, JapanDepartment of Neurosurgery, Saga University, Saga 849-8501, JapanDepartment of Neurosurgery, Saga University, Saga 849-8501, JapanDepartment of Neurosurgery, Saga University, Saga 849-8501, JapanDepartment of Neurosurgery, Saga University, Saga 849-8501, JapanDepartment of Neurosurgery, Saga University, Saga 849-8501, JapanDepartment of Neurosurgery, Saga University, Saga 849-8501, JapanThe development of potent and selective therapeutic approaches to glioblastoma (GBM) requires the identification of molecular pathways that critically regulate the survival and proliferation of GBM. Glioblastoma stem-like cells (GSCs) possess stem-cell-like properties, self-renewal, and differentiation into multiple neural cell lineages. From a clinical point of view, GSCs have been reported to resist radiation and chemotherapy. GSCs are influenced by the microenvironment, especially the hypoxic condition. N-myc downstream-regulated gene 1 (NDRG1) is a tumor suppressor with the potential to suppress the proliferation, invasion, and migration of cancer cells. Previous studies have reported that deregulated expression of NDRG1 affects tumor growth and clinical outcomes of patients with GBM. This literature review aimed to clarify the critical role of NDRG1 in tumorigenesis and acquirement of resistance for anti-GBM therapies, further to discussing the possibility and efficacy of NDRG1 as a novel target of treatment for GBM. The present review was conducted by searching the PubMed and Scopus databases. The search was conducted in February 2022. We review current knowledge on the regulation and signaling of NDRG1 in neuro-oncology. Finally, the role of NDRG1 in GBM and potential clinical applications are discussed.https://www.mdpi.com/2076-3425/12/4/473N-myc downstream-regulated gene 1glioblastomaglioblastoma stem-like cells
spellingShingle Yukiko Nakahara
Hiroshi Ito
Hiroki Namikawa
Takashi Furukawa
Fumitaka Yoshioka
Atsushi Ogata
Jun Masuoka
Tatsuya Abe
A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas
Brain Sciences
N-myc downstream-regulated gene 1
glioblastoma
glioblastoma stem-like cells
title A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas
title_full A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas
title_fullStr A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas
title_full_unstemmed A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas
title_short A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas
title_sort tumor suppressor gene n myc downstream regulated gene 1 ndrg1 in gliomas and glioblastomas
topic N-myc downstream-regulated gene 1
glioblastoma
glioblastoma stem-like cells
url https://www.mdpi.com/2076-3425/12/4/473
work_keys_str_mv AT yukikonakahara atumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT hiroshiito atumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT hirokinamikawa atumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT takashifurukawa atumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT fumitakayoshioka atumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT atsushiogata atumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT junmasuoka atumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT tatsuyaabe atumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT yukikonakahara tumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT hiroshiito tumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT hirokinamikawa tumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT takashifurukawa tumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT fumitakayoshioka tumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT atsushiogata tumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT junmasuoka tumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas
AT tatsuyaabe tumorsuppressorgenenmycdownstreamregulatedgene1ndrg1ingliomasandglioblastomas